Department of Public Health, Kampala International University-Western Campus, Ishaka, Uganda.
Department of Medical Laboratory Science, Kampala International University-Western Campus, Ishaka, Uganda.
BMC Public Health. 2024 May 31;24(1):1467. doi: 10.1186/s12889-024-19001-y.
Screening for sickle cell traits before marriage or producing children is one of the outstanding preventive measures for sickle cell disease (SCD).The disease is a collection of inherited blood disorders that impact millions globally, with a predominant 75% occurrence in the sub-Saharan region. With increasing burden of SCD on the continent amidst a cost effective prevention method, no study has systematically reviewed or presented meta-analytic uptake or practice of premarital sickle cell trait screening.
This review systematically explored the uptake or practice of premarital genotype screening in Africa. We searched PubMed and Scopus databases for African studies on premarital screening for sickle cell traits.
Our results indicate that the pooled uptake of premarital sickle cell trait screening in Africa is 47.82% (95% CI: [46.53-49.11]; I: 98.95% [98.74-99.13]). Our review observed, a significant relationship between the awareness of sickle cell disease and the uptake of genotype screening; F(1, 13) = 12.04, p = 0.004). The model explained approximately 48.08% of the variation in genotype screening (R² = 0.4808) and predicted a 0.729 increase in the likelihood of genotype screening uptake for every unit rise in sickle cell disease awareness (β = 0.729, p = 0.004). Additionally, Pearson correlation (r = 0.6934) indicated a moderately strong positive correlation between the two variables.
With over 75% of the global burden of sickle cell disease domiciled in Africa, the continent cannot overlook the cost of hemoglobinopathies. The uptake of sickle cell traits screening is suboptimal across the continent. To achieve the mandate of sustainable development goal number (3); to end preventable deaths of newborns and children under 5 years of age by 2030, there is need to intensify campaigns on premarital genetic screening through education and other health promotion tools.
在婚前或生育前筛查镰状细胞特征是预防镰状细胞病(SCD)的一项重要措施。该病是一组遗传性血液疾病,影响着全球数百万人,其中撒哈拉以南地区的发病率高达 75%。由于 SCD 在非洲的负担日益加重,而这种疾病可以通过一种具有成本效益的预防方法进行控制,但目前尚无研究系统地评估或呈现婚前镰状细胞特征筛查的采用或实施情况。
本综述系统地探讨了非洲婚前基因型筛查的采用或实施情况。我们在 PubMed 和 Scopus 数据库中搜索了关于非洲婚前镰状细胞特征筛查的研究。
我们的研究结果表明,非洲婚前镰状细胞特征筛查的总体采用率为 47.82%(95%CI:[46.53-49.11];I²:98.95%[98.74-99.13])。我们的研究还观察到,对镰状细胞病的认识与基因型筛查的采用之间存在显著关系;F(1, 13)= 12.04,p = 0.004)。该模型解释了基因型筛查采用情况变化的约 48.08%(R²=0.4808),并预测对镰状细胞病认识程度每提高一个单位,基因型筛查采用的可能性就会增加 0.729(β=0.729,p=0.004)。此外,Pearson 相关系数(r=0.6934)表明这两个变量之间存在中度强正相关。
由于全球超过 75%的镰状细胞病负担发生在非洲,非洲大陆不能忽视血红蛋白病的代价。整个非洲大陆的镰状细胞特征筛查采用率不理想。为了实现可持续发展目标 3 的目标,即在 2030 年之前结束可预防的新生儿和 5 岁以下儿童死亡,需要通过教育和其他健康促进工具加强婚前遗传筛查运动。